Loading ETF profile…
يهدف صندوق First Trust NYSE Arca Biotechnology Index Fund (FBT) المتداول في البورصة (ETF) إلى عكس تحركات الأسعار والدخل الناتج عن مؤشر NYSE Arca Biotechnology Index بدقة. يتمثل هدفه الأساسي في مطابقة أداء هذا المؤشر المرجعي عن كثب، قبل احتساب رسوم ونفقات تشغيل الصندوق.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc. | 5.66% | $159.16M |
| VCYT | Veracyte, Inc. | 5.22% | $146.93M |
| NEO | NeoGenomics, Inc. | 5.00% | $140.64M |
| BRKR | Bruker Corporation | 4.28% | $120.56M |
| ALKS | Alkermes Plc | 4.25% | $119.51M |
| ILMN | Illumina, Inc. | 4.04% | $113.66M |
| KRYS | Krystal Biotech, Inc. | 3.94% | $110.81M |
| NTRA | Natera, Inc. | 3.81% | $107.07M |
| AXSM | Axsome Therapeutics, Inc. | 3.65% | $102.75M |
| NBIX | Neurocrine Biosciences, Inc. | 3.56% | $100.10M |
| TECH | Bio-Techne Corporation | 3.44% | $96.89M |
| BIIB | Biogen Inc. | 3.38% | $95.05M |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 3.33% | $93.79M |
| EXEL | Exelixis, Inc. | 3.31% | $93.06M |
| INCY | Incyte Corporation | 3.22% | $90.58M |
| VRTX | Vertex Pharmaceuticals Incorporated | 3.09% | $86.92M |
| ARGX | argenx SE (ADR) | 3.08% | $86.60M |
| RGEN | Repligen Corporation | 3.08% | $86.58M |
| HALO | Halozyme Therapeutics, Inc. | 3.07% | $86.37M |
| BMRN | BioMarin Pharmaceutical Inc. | 2.85% | $80.27M |
| AMGN | Amgen Inc. | 2.77% | $77.96M |
| BNTX | BioNTech SE (ADR) | 2.66% | $74.91M |
| UTHR | United Therapeutics Corporation | 2.57% | $72.34M |
| ONC | BeOne Medicines Ltd. (ADR) | 2.53% | $71.08M |
| GMAB | Genmab A/S (ADR) | 2.48% | $69.91M |